Predictors and Long-Term Outcomes for Diffuse Large B-Cell Lymphoma (DLBCL) Patients Undergoing Surgery Prior to Systemic Therapy: A Nationwide Analysis

Background: A minority of patients diagnosed with diffuse large B-cell lymphoma (DLBCL) undergo surgery before the initiation of systemic therapy. The aim of this study is to explore the characteristics of patients undergoing surgery prior to systemic therapy (surgfirst), the predictors for surgfirs...

Descripción completa

Detalles Bibliográficos
Autores principales: Vusqa, Urwat, Jayakrishnan, Thejus T, Bakalov, Veli, Chahine, Zena, Wegner, Rodney, Khan, Cyrus, Fazal, Salman, Samhouri, Yazan, Malayala, Srikrishna V, Lister, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128759/
https://www.ncbi.nlm.nih.gov/pubmed/35637830
http://dx.doi.org/10.7759/cureus.24448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128759/
https://www.ncbi.nlm.nih.gov/pubmed/35637830
http://dx.doi.org/10.7759/cureus.24448

Ejemplares similares